Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

New MAP kinase-activated protein kinase 2 inhibitors discovered

July 19, 2011

Novel imidazo[1,2-b]pyridazine derivative ameliorates symptoms of arthritis in vivo

July 19, 2011

Evotec discloses new voltage-gated K(V)1.3 potassium channel blockers

July 15, 2011

Sanofi and Regeneron report phase IIb data on sarilumab

July 14, 2011

Novel MK2 inhibitors synthesized at Merck & Co.

July 14, 2011

Treatment begins in phase Ib Ampion trial in osteoarthritis of the knee

July 12, 2011

GSK presents new selective lysophospholipid S1P1 receptor agonist with promise to treat arthritis

July 7, 2011

Amgen and UCB join with NASA to test sclerostin-targeted antibody onboard space shuttle Atlantis

July 6, 2011

Janssen obtains Japanese manufacturing and marketing license for Simponi in RA

July 5, 2011

AN-6414 is safe and improves symptoms of arthritis in preclinical studies

July 5, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...